(4-Methylpiperazin-1-yl)piperidin-4-yl-methanone, 97.0%, 1g

2,8-Dibromodibenzofuran>98.0%(GC)1g

(R)-1-(4-(Trifluoromethyl)phenyl)propan-1-amine hydrochloride, 97%, 100mg

Bromoacetonitrile>97.0%(GC)500g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyloct-7-enoic acid, 95.0%, 250mg

GC capillary column ROTI®Cap-5, 10 m, 0.10 mm, 0.10 µm, 1 Piece(s)

4,4',4''-TRIS(N-3-METHYLPHENYL-N-PHENYLAMINO)TRIPHENYLAMINE, 98%, 25g

(3-Bromo-4-methylphenoxy)(tert-butyl)dimethylsilane, 95.0%, 100g

1,4-Bis[4-(3-acryloyloxypropoxy)benzoyloxy]-2-methylbenzene>98.0%(HPLC)1g

4-(5-Methyl-furan-2-yl)-phenylamine oxalic acid salt, 1g

2,7-Dichloroquinoline-3-carbaldehyde, 95%, 5g

[4-(2-fluorocyclopropyl)phenyl]methanol, 98%, 100mg

4,6-DIMETHOXY-ISOPHTHALIC ACID DIETHYL ESTER, 95.0%, 250mg